Aodong Brand Ranking
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Aodong

Aodong

Jilin Aodong Pharmaceutical Group Co., Ltd.
If you want to improve the ranking of your company brand or wish to avoid appearing here, please contact trading@bossgoo.com.
Brand Introduction

The company was the state-owned Yanbian Dunhua Luchang established in 1957. Aodong Pharmaceutical Factory was established in 1981. In 1993, Yanbian Aodong Pharmaceutical (Group) Co., Ltd. was established with the approval of the Jilin Provincial Economic System Reform Commission. It was renamed in 1998. Jilin Aodong Pharmaceutical Group Co., Ltd. was listed on the Shenzhen Stock Exchange on October 28, 1996. In 2001, Jilin Aodong established a parent-subsidiary system and gradually developed into a holding group listed company based on the pharmaceutical industry and developed with a multi-wheel drive model of "pharmaceutical + finance + big health". Since the establishment of Aodong Pharmaceutical Factory, it has adhered to the traditional virtue of "relief the world", adhered to the business philosophy of "health in the world, Aodong's responsibilities", provided safe, reliable and reliable medicines to the society, and promoted the renewal of production equipment. Technology is constantly improving, and we have won the continuous trust of consumers with the excellence of product quality. Currently, the company has a total of 22 subsidiaries, including 6 professional pharmaceutical subsidiaries engaged in modern traditional Chinese medicine, biochemical drugs and phytochemical drugs, 1 pharmaceutical R&D subsidiary, 5 pharmaceutical sales subsidiaries, and 6 pharmaceutical supporting subsidiaries. , 2 health products companies, 1 road construction toll company, and 1 Aodong International (Hong Kong) Industrial Co., Ltd.

After decades of development, the company has built the core competitiveness of the company:

1. Inheriting Chinese medicine culture and promoting the essence of Chinese medicine Aodong brand advantages

The "Aodong and Tu" trademark is a valuable intangible asset formed by the company for more than 40 years since its establishment of a pharmaceutical factory, inheriting the culture of Chinese medicine, carrying forward the essence of Chinese medicine, and experiencing brand establishment, brand expansion and brand maintenance. At the same time, the company's products have won the general recognition of the general public for their "excellent quality and reasonable price" and have achieved good reputation and reputation.

2. The quality advantages of every medicine and every pill are safe, reliable and reliable

The company has always adhered to the original mission of producing "safe, reliable and reliable medicine", implemented strict quality management, adhered to strict source control, process control, and risk prevention to ensure better product quality. The company has the National Enterprise Technology Center and the National Postdoctoral Research Station. The company has formulated enterprise internal control standards that are higher than the national statutory standards, established the concept of "quality is the life of the enterprise", upholds the spirit of "craftsmanship" to strictly manage product quality, continuously improve the quality of drugs, strive for excellence in products, and ensures that every drug and every A pill is safe, reliable and reliable.

3. Technical advantages of intelligent manufacturing and digital lean production

The company adheres to craftsmanship and adheres to excellent quality. Always adhere to the core values ​​of "focusing on people and specializing in medicine", adhere to the development path of "technology to develop enterprises" and "technology to strengthen enterprises", constantly carry out technological innovation, and adopt full-process online detection and analysis technology in production, and establish The automated production line of traditional Chinese medicine extraction adopts advanced technologies such as modern biological chromatography separation technology, centrifugal separation, organic solvent grading precipitation, and promotes lean production, and the production process gradually transforms from automation and informatization to intelligence and digitalization. In order to improve production capacity and consolidate the comprehensive capabilities of the main pharmaceutical business, the company has built an Aodong Industrial Park industrial cluster with advanced technology, energy conservation and environmental protection, and complete functions. After years of development, the company has embarked on a development path of original innovation, introduction, digestion, absorption and reinnovation, and has continuously improved the modernization level of traditional Chinese medicine manufacturing.

4. Innovate the management advantages of modern enterprise systems to activate the vitality of enterprises

The company has continuously innovated and improved the modern enterprise system and transformed into a holding group company with the "parent and subsidiary" management system in 2002. The parent company organizes the formulation and implementation of the group's long-term planning and development strategy, carries out capital operation activities such as investment and financing, corporate mergers and acquisitions, and the subsidiary company operates flexibly, enjoys the rights of independent operations, and implements specific R&D, production and sales enterprise operations. The mother and son The company system enhances the group portfolio effect, and the company's overall development is dynamic and sustainable.

5. The capital advantage of building the integration of industry and finance by holding high-quality financial assets

The company has established a multi-wheel drive growth model of "pharmaceutical + finance + big health" to help the development of the real industry with financial advantages. The company has always been based on the pharmaceutical industry to seek development. By investing in GF Securities' equity and managing market value in a timely manner, it has become the major shareholder of GF Securities. GF ​​Securities is the company's core high-quality asset and has built a core position in the company's capital advantage.

The company's main products include "Anshen Bu Brain Liquid", "Xiaolean Chaigui Deheat Oral Liquid", "Naoxinshu Oral Liquid", "Xuefu Zhuyu Oral Liquid", "Ribonic Nucleic Acid II for Injection", and "Hydrochloric Acid for Injection Pingyangmycin", "Yangxueyin Oral Liquid", "Shenfukang Tablets", "Shaofu Zhuyu Granules", "Shenjin Tablets", "Vitamin C Efferve Tablets", "Cold Qingre Capsules", "Injection Use lysapilin, "lingbei cough syrup", "shengmaiyin", etc.

Recommend Related Products

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628

浙公网安备 33020902000078号